Breaking News, Collaborations & Alliances

Recipharm and LIDDS Form Mfg. Pact

Establish industrial manufacturing capabilities for a novel prostate cancer product

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Recipharm and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm in Solna, Sweden. The manufacturing line is dedicated to the first product based on LIDDS’ NanoZolid technology. Clinical trial material has already been produced and the facility is ready for future commercial manufacturing of Liproca Depot or other pharmaceutical formulations based on the NanoZolid technology. The manufacturing line has been adapted for GMP produc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters